What Is the MILD Procedure for Spinal Stenosis?

The MILD procedure (minimally invasive lumbar decompression) is an outpatient spine treatment that removes small portions of thickened tissue and bone at the back of the spinal canal to relieve pressure on the nerves in your lower back. It is designed specifically for people with lumbar spinal stenosis whose symptoms stem from a thickened ligamentum flavum, a band of tissue that lines the spinal canal and can crowd the nerves as it enlarges over time. The procedure uses specialized tools guided by real-time imaging, requires no implants or stitches, and typically takes under an hour. Its place in the treatment landscape sits between conservative therapies that have stopped working and traditional open surgery, and the evidence supporting it has grown considerably over the past decade.

Why the Ligamentum Flavum Matters

The ligamentum flavum is a band of elastic tissue that runs along the back wall of the spinal canal, connecting each pair of vertebrae. In a healthy spine it is thin and flexible, but with age, degeneration, and mechanical stress, it can thicken and stiffen. This thickening is recognized as the single most important contributor to lumbar spinal canal stenosis, because unlike bony changes that progress slowly and symmetrically, the ligament can bulge inward enough to significantly narrow the space available for your spinal nerves.¹

The clinical consequence is neurogenic claudication, the hallmark symptom of lumbar stenosis: pain, heaviness, or numbness in the legs that worsens with standing and walking and eases when you sit down or lean forward. Research has found that the thickness of the ligamentum flavum is the strongest independent predictor of how severe that claudication becomes, more so than disc bulging or bony overgrowth.² The MILD procedure exists specifically because this tissue is accessible from the back of the spine without having to cut through muscle or remove large amounts of bone.

What Happens During the Procedure

MILD is performed through a tiny incision, roughly the diameter of a pencil eraser, in the skin of the lower back. You lie face-down, and the physician uses fluoroscopic (live X-ray) guidance to position specialized instruments at the affected spinal level. Through that single access point, the physician removes small pieces of thickened ligamentum flavum and, when necessary, trims a sliver of the bony lamina that forms the roof of the spinal canal. The goal is to restore enough space inside the canal for the nerves to decompress without removing the structural elements that keep the spine stable.

Because the procedure avoids implants, general anesthesia, and significant bone removal, it preserves the architecture of the spine. Most patients receive moderate sedation and local anesthesia. The lack of implants also means there are no foreign-body complications like device migration or breakage, a distinction that becomes relevant when comparing MILD to alternatives such as interspinous spacers.

Pain and Disability Outcomes

The strongest efficacy data comes from the MOTION study, a randomized controlled trial that compared MILD plus conservative medical management to conservative management alone. At one year, the MILD group saw a mean improvement of about 16 points on the Oswestry Disability Index (a standard questionnaire measuring how much back pain affects daily activities), compared with a 2-point improvement in the conservative-care group. Pain scores for both back and leg pain, along with measures of physical function and symptom severity, all favored MILD by a wide margin.³

Earlier quality-assurance data showed roughly two-thirds of patients reporting less pain at three months, and about a quarter achieving at least a 20 percent improvement in functional disability at six months.⁴ That quality-assurance report used a more real-world patient mix, and the somewhat more modest numbers likely reflect the range of outcomes you can expect outside of a tightly controlled trial. Still, the overall direction is consistent: most patients experience meaningful pain relief and improved function.

How Much Walking Improves

For many people with lumbar stenosis, the ability to walk without stopping for pain is the outcome they care most about. Early prospective data showed walking distance jumping from an average of roughly 250 feet before the procedure to nearly 4,000 feet afterward, and standing tolerance rising from about eight minutes to nearly an hour.⁵ Those are dramatic numbers, though they come from a single-arm study without a control group.

The MOTION trial addressed that limitation by including an objective walking-tolerance test with a control arm. MILD patients improved their walking time to onset of severe symptoms by an average of about 258 percent at one year, compared with 64 percent in the conservative-care group.³ That controlled comparison makes the walking gains harder to dismiss as placebo or natural fluctuation.

Do the Benefits Last?

One concern with any minimally invasive spine procedure is whether the relief fades as the body heals and scar tissue forms. The MOTION trial’s five-year follow-up provides the longest controlled look at durability. At five years, patients who received MILD still showed significant improvements over their baseline in disability scores, back and leg pain, symptom severity, and physical function. Walking times had increased roughly 326 percent from pre-procedure levels.⁶ Three additional spine interventions were performed in the MILD group during the interval between the three-year and five-year visits, which is a relatively low rate of escalation over two years.

Separate follow-up data showed that pain relief and reduced opioid use remained statistically significant at twelve months, with statistically meaningful drops in opioid prescriptions even though only about a quarter of patients were using opioids before the procedure.⁷ The fact that opioid reduction persisted is noteworthy because spine procedures can sometimes trade one form of pain management for another without truly lowering medication dependence.

MILD Versus Epidural Steroid Injections

Epidural steroid injections are one of the most common treatments for lumbar stenosis pain, so many patients wonder how MILD stacks up. A randomized, double-blind trial directly compared the two. At six and twelve weeks, patients treated with MILD reported significantly greater pain reduction and better functional mobility than those who received epidural steroids. Patient satisfaction scores also favored MILD at both time points.⁸

The safety profile of MILD has been described as roughly equivalent to that of epidural steroid injections, which is a reassuring comparison given that epidurals are generally considered low-risk procedures.⁹ That combination of better efficacy and similar safety is why some treatment algorithms now position MILD as the next step after conservative care fails, rather than defaulting to another round of steroid injections.

MILD Versus Open Surgery

Comparing MILD to traditional laminectomy (open surgical decompression) is more nuanced because the two procedures target somewhat different patient populations, and the trade-offs involve both effectiveness and risk. A large Medicare claims analysis of over several thousand patients found that the rate of procedure-related harms for MILD was roughly a third of the rate seen with laminectomy (about 1.9 percent versus 5.8 percent). However, MILD patients were somewhat more likely to need a subsequent surgical procedure (9.0 percent versus 5.5 percent for laminectomy). When harms and subsequent procedures were combined into a single composite measure, the two approaches were essentially equivalent, at about 11 percent each.¹⁰

A separate propensity-matched analysis painted a less favorable picture for MILD on reoperation rates, finding that 46 percent of MILD patients eventually required reoperation compared with about 29 percent of open-decompression patients.¹¹ That is a striking gap, and it likely reflects the fact that MILD removes less tissue overall: when stenosis progresses or recurs, there is a greater chance the patient will need further intervention. A broader systematic review, however, reported that observational studies generally found subsequent surgical intervention rates at or under 12 percent within five years.¹²

The discrepancy between these numbers deserves some attention. The propensity-matched study drew from a claims database where patient selection may have differed from trial populations, and longer follow-up windows naturally catch more reoperations. The Medicare benchmark study used a two-year window, while the propensity-matched analysis tracked patients longer. Both findings can be true simultaneously: MILD has a higher reoperation rate than open surgery over time, but for many patients the trade-off is worth it because the initial procedure is far less invasive, carries fewer complications, and preserves the option of surgery later if needed.

Safety Profile

Across the published literature, the MILD procedure has an unusually clean safety record for a spine intervention. Multiple studies have reported zero major device-related or procedure-related serious adverse events.¹³ Reviews have echoed this finding, noting that complication rates are much lower than those of open surgery and that the procedure preserves the structural stability of the spine.¹⁴

The Medicare claims comparison with interspinous spacers adds another angle. Among over 2,200 MILD patients and 3,400 spacer patients tracked for two years, the harm rate for MILD was less than half that of spacers (about 5.6 percent versus 12.1 percent). Rates of subsequent interventions were similar between the two groups, at roughly 25 percent each.¹⁵ The takeaway is that when choosing among minimally invasive options that avoid open surgery, MILD’s safety edge over implant-based devices is substantial.

Who Is a Good Candidate

MILD is not a fit for every kind of lumbar stenosis. The procedure targets neurogenic claudication caused by a thickened ligamentum flavum, so imaging needs to confirm that the ligament is in fact contributing to the narrowing. If your stenosis is primarily caused by a large disc herniation, bony overgrowth alone, or something else that MILD’s instruments cannot address, the procedure will not help.

It is generally recommended as the first procedural step after conservative measures like physical therapy, pain medications, and epidural steroid injections have been tried and have not provided adequate relief.⁹ The procedure is contraindicated in patients with conditions that increase spinal instability. These include severe disc herniations, spinal infection (osteomyelitis), and spondylolisthesis greater than grade 1 (meaning one vertebra has slipped more than 25 percent forward over the one below it).¹⁶ Because the procedure removes only a thin layer of tissue and bone, it relies on the rest of the spine remaining structurally sound.

Age alone is not a barrier. In fact, MILD’s outpatient nature and avoidance of general anesthesia make it particularly appealing for older adults who may not tolerate open surgery well. Many of the study populations have been Medicare-age patients, and the safety data reflects that demographic.

Cost-Effectiveness

Healthcare cost matters, especially for older adults who may be weighing several treatment rounds against a single larger intervention. A cost-effectiveness analysis comparing three common strategies found that MILD was the most cost-effective option over two years, followed by epidural steroid injections, with laminectomy surgery being the least cost-effective.¹⁷ That analysis factored in not just the cost of the procedure itself but also follow-up visits, repeat interventions, and quality-of-life gains.

Part of MILD’s cost advantage comes from the fact that it is performed in an ambulatory surgery center or outpatient hospital setting. There is no overnight stay, no prolonged recovery requiring rehabilitation, and patients typically resume light activities within days. Open laminectomy, by contrast, often involves a hospital admission, a longer recovery, and more physical therapy. For patients covered by Medicare, MILD has been a covered procedure since 2014, which has widened access considerably.

What MILD Cannot Do

It is worth being clear about the procedure’s limits. MILD addresses one component of stenosis, the thickened ligamentum flavum, and to a lesser extent a small amount of bone. It does not treat significant disc herniations, facet joint arthritis, or spinal instability. If your stenosis is driven primarily by those factors, MILD is unlikely to provide meaningful relief, and open surgery or fusion may be more appropriate.

The procedure also treats one or two spinal levels at a time. If you have extensive multilevel stenosis, your physician may need to stage treatments or consider a more comprehensive approach. And while the five-year MOTION trial data is encouraging, MILD is still a relatively young procedure compared with laminectomy, which has decades of long-term outcome data. Patients who choose MILD should understand that they are accepting a somewhat higher chance of needing a future procedure in exchange for a dramatically lower risk of complications and a faster recovery today. For many people, especially those who are older or have other health conditions that make open surgery risky, that is a reasonable trade.

How Recovery Typically Goes

Recovery from MILD is faster than most patients expect from anything labeled a “spine procedure.” Because the incision is small and no muscle is cut, post-procedure soreness is usually manageable with over-the-counter pain medication. Most patients go home within a few hours and can return to light daily activities within a day or two. Your physician will typically advise avoiding heavy lifting and strenuous exercise for a few weeks to let the access site heal, but the restrictions are far milder than those following open spinal surgery.

Some patients notice improvement in their walking tolerance within the first week, while for others the full benefit takes a few weeks to develop as inflammation from the procedure itself settles. Physical therapy is often recommended afterward to rebuild strength and endurance in the legs and core, since many patients have been limiting their activity for months or years before the procedure. The combination of decompression and targeted rehabilitation tends to produce the best functional outcomes, because restoring nerve space does not automatically restore the muscle conditioning that was lost during the period of limited mobility.